Accueil / Tag Archives: Washington (page 20)

Tag Archives: Washington

Adaptive Biotechnologies® Publishes Ground-Breaking Proof-of-Principle Experiment in Nature Genetics

Tuesday, April 4th 2017 at 6:41pm UTC Study Demonstrates Potential for a Fundamentally New Way to Diagnose Chronic Viral Infections SEATTLE–(BUSINESS WIRE)– Adaptive Biotechnologies, the leader in combining next-generation sequencing and expert bioinformatics to profile T-cell and B-cell receptors (TCRs and BCRs) of the adaptive immune system, today announced that …

Plus »

Seattle Genetics Presents Data Advancing Antibody-Drug Conjugate and Novel Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting

Monday, April 3rd 2017 at 12:00pm UTC BOTHELL, Wash.–(BUSINESS WIRE)– Seattle Genetics, Inc. (Nasdaq: SGEN), a global biotechnology company, today highlighted multiple data presentations that support the company’s advancing antibody-drug conjugate (ADC) and immuno-oncology programs at the upcoming 108th Annual Meeting of the American Association for Cancer Research (AACR) being …

Plus »

Transgene Presents Very Promising New Immunology Data of its Next Generation Armed Oncolytic Virus at the AACR Annual Meeting in Washington, DC

Thursday, March 30th 2017 at 3:45pm UTC STRASBOURG, France–(BUSINESS WIRE)– Regulatory News: Transgene (Paris:TNG), a biotechnology company focused on designing and developing viral-based immune-targeted therapies for the treatment of cancers and infectious diseases, announces today that it will present a poster with new and encouraging preclinical data of a next …

Plus »

BIO Ventures for Global Health Expands Its Board to Strengthen Its Nonprofit Global Health Expertise

Friday, March 31st 2017 at 9:00am UTC SEATTLE–(BUSINESS WIRE)– BIO Ventures for Global Health (BVGH), a nonprofit global health organization, announced today that Dr. Stefan Kaufmann, Founding Director of the Max Planck Institute for Infection Biology; and Dr. Groesbeck Parham, Professor of Obstetrics and Gynecology at the University of North …

Plus »

HISTALIM renforce son positionnement sur l’IHC multiplexe et les tests-compagnons en intégrant deux nouvelles plateformes commercialisées par Roche Diagnostics France

Friday, March 31st 2017 at 4:42pm UTC MONTPELLIER, France–(BUSINESS WIRE)– Les récents développements dans le domaine de l’immunothérapie des cancers nécessitent un besoin croissant en analyse tissulaire. Caractériser le microenvironnement tumoral et son interaction immunitaire avec la tumeur est un enjeu stratégique en immuno-oncologie. C’est ce que propose HISTALIM qui …

Plus »

Blaze Bioscience Announces Tumor Paint BLZ-100 Publication in International Journal of Toxicology

Tuesday, March 28th 2017 at 10:00am UTC Safety pharmacology, PK and toxicology studies supported first-in-human clinical trials SEATTLE–(BUSINESS WIRE)– Blaze Bioscience, Inc., the Tumor Paint Company®, a biotechnology company dedicated to improving the lives of cancer patients, today announced the publication of a peer-reviewed manuscript in International Journal of Toxicology …

Plus »

Seattle Genetics Highlights Leadership in Antibody-Drug Conjugate Technology Innovation at the American Association for Cancer Research (AACR) Annual Meeting

Thursday, March 30th 2017 at 12:00pm UTC -14 presentations, including four orals, illustrate advances in ADC technology and multiple development programs- BOTHELL, Wash.–(BUSINESS WIRE)– Seattle Genetics, Inc. (Nasdaq: SGEN), a global biotechnology company, today announced its broad presence at the upcoming 108th Annual Meeting of the American Association for Cancer …

Plus »

Madison Vaccines Incorporated Expands Clinical Trial of MVI-118 for Prostate Cancer to University of Washington

Tuesday, March 21st 2017 at 1:03pm UTC — MVI-118, Gene-based Immunotherapy, Is Intended to Delay Disease Progression in Men with Metastatic Prostate Cancer — MADISON, Wis. & SEATTLE–(BUSINESS WIRE)– Madison Vaccines Incorporated (MVI), a clinical stage company developing gene-based immunotherapies, today said that the Phase 1 clinical trial of MVI-118 …

Plus »

Castle Biosciences’ DecisionDx-Melanoma Test Shown to be a Significant Predictor of Distant Metastasis in Elderly Patients with Melanoma

Monday, March 20th 2017 at 12:00pm UTC Additional independent studies presented at the 70th Society of Surgical Oncology Annual Cancer Symposium confirm performance and clinical impact of test FRIENDSWOOD, Texas–(BUSINESS WIRE)– Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment decisions, today announced that studies evaluating the prognostic performance and …

Plus »

New Study Shows Prevencio’s Simple Blood Test Determines Risk of Heart Attack, Stroke, or Cardiovascular Death

Friday, March 17th 2017 at 10:00am UTC Novel multi-protein test data presented at American College of Cardiology Scientific Sessions demonstrate 97 percent accuracy (negative predictive value) KIRKLAND, Wash.–(BUSINESS WIRE)– Prevencio, Inc. today announces the presentation of data which demonstrate that a simple blood test is more accurate than commonly-used risk …

Plus »
>
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LmJpb3RlY2gtZmluYW5jZXMuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDE1LzA3L1NhdHJhLTIubXA0IiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...
S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.

S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.